Laminar inflammatory gene expression in the carbohydrate overload model of equine laminitis

Reasons for performing study: There is a need to assess the laminar inflammatory response in a laminitis model that more closely resembles clinical cases of sepsis‐related laminitis than the black walnut extract (BWE) model. Objectives: To determine if a similar pattern of laminar inflammation, characterised by proinflammatory cytokine expression, occurs in the CHO model of laminitis as has been previously reported for the BWE model. Methods: Sixteen horses administered 17.6 g of starch (85% corn starch/15% wood flour)/kg bwt via nasogastric (NG) tube were anaesthetised either after developing a temperature >38.9°C (DEV group, n = 8) or at onset of Obel grade 1 lameness (OG1 group, n = 8). Control horses (CON group, n = 8) were anaesthetised 24 h after NG administration of 6 l of deionised water. Laminar tissue was collected from horses while under anaesthesia, followed by humane euthanasia. Real time‐quantitative PCR was used to assess laminar mRNA concentrations of genes involved in inflammatory signalling. Results: Increased mRNA concentrations (P<0.05) for IL‐1β, IL‐6, IL‐12p35, COX‐2, E‐selectin and ICAM‐1 were present in laminae from horses with OG1 lameness but not at the DEV time, when compared to the CON horses. No differences between the groups were found for IL‐2, IL‐4, IL‐10, TNF‐α, IFN‐γ or COX‐1 at either the DEV or OG1 time points. Conclusions: There was a notable difference in the temporal pattern of inflammatory events between the BWE and CHO models, with the majority of laminar inflammatory events appearing to occur at or near the onset of lameness in the CHO model, whereas many of these events peak earlier in the developmental stages in the BWE model. This suggests that, in addition to circulating inflammatory molecules, there may be a local phenomenon in the CHO model resulting in the simultaneous onset of multiple laminar events including endothelial activation, leucocyte emigration and proinflammatory cytokine expression. Potential relevance: The similar (although somewhat delayed) inflammatory response in the CHO model of laminitis indicates that inflammatory signalling is a consistent entity in the pathophysiology of laminitis.     

湖南省山羊脑多头蚴的线粒体nad1和nad4基因的序列测定及种系发育分析

本研究旨在阐明脑多头蚴湖南分离株线粒体烟酰胺腺嘌呤二核苷酸( NADH)脱氢酶亚单位1基因(nad1)部分序列(pnad1)和烟酰胺腺嘌呤二核苷酸(NADH)脱氢酶亚单位4基因(nad4)部分序列(pnad4)的遗传变异情况,并用pnad1和pnad4序列重构脑多头蚴与其它带科绦虫的种群遗传关系.利用聚合酶链反应(PCR)扩增脑多头蚴的pnad1和pnad4,应用ClustalX 1.81程序对序列进行比对,再用Phylip3.67程序MP法和Mage4.0程序NJ法绘制种系发育树,并用Puzzle5.2程序构建最大似然树,同时利用DNAstar5.0中的Megalign程序进行同源性分析.结果显示所获得的pnad1和pnad4序列长度分别均为666和887 bp,湖南分离株与已知多头带绦虫位于同一分枝.由于脑多头蚴pnad1和pnad4序列种内相对保守,种间差异较大,故均可作为种间遗传变异研究的标记,从而为脑多头蚴的分子流行病学和其相关疾病的诊断奠定基础.     

玉屏风散对小鼠β防御素-2基因表达的影响

研究玉屏风散益气固表、提高机体对环境病因抵抗力的机理。实验组6只小鼠以玉屏风散水煎液灌胃10 d,对照组6只小鼠给予同体积生理盐水,处死动物后提取肺组织总RNA,通过实时荧光定量PCR测定小鼠在灌服玉屏风散水煎液后β防御素-2基因表达水平。结果实验组小鼠β防御素-2基因的相对表达量是对照组的9.327倍。表明玉屏风散增强机体抵抗力与其可上调β防御素-2基因的表达从而提高机体非特异性免疫力有关。     

乳铁蛋白的生物学功能及其基因工程研究进展

乳铁蛋白是一种具有多种生物活性的糖蛋白。本文主要就乳铁蛋白的生物学功能及其基因工程研究进展作一综述。     

鸡肠炎沙门氏菌外膜蛋白F的原核表达及免疫原性分析

根据GenBank中收录的鸡肠炎沙门氏菌OmpF基因序列设计1对引物,以鸡肠炎沙门氏菌辽宁分离株基因组为模板,扩增鸡肠炎沙门氏菌OmpF基因,用IEDB Analysis Resource在线预测分析,该基因可能存在15个线性B细胞抗原表位;同时将该基因克隆至原核表达载体PGEX-4T-1中,构建重组表达质粒PGEX-4T-1-OmpF,转入大肠杆菌BL21中,获得OmpF重组蛋白。Western-blot检测结果表明,该重组蛋白的分子质量约为66 kD(含标签蛋白),能被鸡沙门氏菌阳性血清识别,初步证实该蛋白具有免疫原性,为鸡肠炎沙门氏菌亚单位疫苗的进一步研究和开发奠定了理论基础。     

Expression of the high mobility group A1 (HMGA1) and A2 (HMGA2) genes in canine lymphoma: analysis of 23 cases and comparison to control cases

Overexpression of high mobility group A (HMGA) genes was described as a prognostic marker in different human malignancies, but its role in canine haematopoietic malignancies was unknown so far. The objective of this study was to analyse HMGA1 and HMGA2 gene expression in lymph nodes of canine lymphoma patients. The expression of HMGA1 and HMGA2 was analysed in lymph node samples of 23 dogs with lymphoma and three control dogs using relative quantitative real‐time RT‐PCR. Relative quantity of HMGA1 was significantly higher in dogs with lymphoma compared with reference samples. HMGA2 expression did not differ between lymphoma and control dogs. With the exception of immunophenotype, comparison of disease parameters did not display any differences in HMGA1 and HMGA2 expression. The present findings indicate a role of HMGA genes in canine lymphoma. This study represents the basis for future veterinary and comparative studies dealing with their diagnostic, prognostic and therapeutic values.     

绵羊PRLR基因内含子9和外显子10多态性与产羔数的关系研究

本研究采用PCR-SSCP技术对绵羊催乳素受体(PRLR)基因内含子9和外显子10部分核苷酸多态性及其与小尾寒羊、中国美利奴(新疆型)绵羊多胎品系、肉用品系、体大品系、萨福克、无角陶赛特、中国美利奴(新疆型)和德国肉用美利奴产羔数间的关系进行了分析。结果发现:①在绵羊PRLR基因内含子9的第259 bp处,存在C→T转换,BB基因型的小尾寒羊平均产羔数分别较AA和AB基因型提高0.81和0.87只(P0.05);②在绵羊PRLR基因外显子10的第304 bp处存在一个G→A转换,该突变导致PRLR基因第387位氨基酸残基由Glu突变为Lys,并使中国美利奴(新疆型)多胎品系中AB基因型的平均产羔数较AA和BB基因型增加0.58和0.80只(P0.05);③在绵羊PRLR基因外显子10第571、585和606bp处分别存在G→A、C→G和C→T突变;其中前2处突变分别导致PRLR基因的第476位氨基酸由Ala突变为Thr,第480位氨基酸由Ser突变为Arg。其中第571 bp处突变导致小尾寒羊AB基因型的平均窝产羔数显著高于AA基因型的窝产羔数,增加0.8只(P0.05)。以上结果提示,PRLR基因可能是控制小尾寒羊和中国美利奴(新疆型)绵羊多胎品系产羔数的主效基因或与之存在紧密的遗传连锁。     

千万不可忽视良种黄牛的保种问题

阐述了良种牛保种的重要意义．基因的随机漂移、选择与杂交、近交是特定基因从群体中消失的主要原因，群体及其有效含量和系统选育的科学组织是保种的重要内容。最后介绍我国良种牛的保种方法及其存在的问题，并提出解决的办法。     

口蹄疫病毒VP1基因密码子偏好性分析

VP1蛋白是口蹄疫病毒(FMDV)的主要结构蛋白,可诱导机体产生中和抗体以及激发保护性免疫应答。为探究VP1基因密码子偏好性,筛选出其最佳体外表达系统,使用Visual Gene Developer、CodonW、GraphPad Prism等软件,对VP1基因进行密码子偏好性分析,同时将VP1基因密码子使用频率与大肠杆菌、毕赤酵母、昆虫杆状病毒和哺乳动物细胞表达系统作了比较。结果显示,VP1基因的CAI为0.21,ENC为55.43,GC3S为65.26%,表明该基因密码子使用偏好较弱并且密码子偏好以G/C碱基结尾。结合VP1基因与各表达系统密码子使用频率比值,发现其与昆虫杆状病毒表达系统频率比值差异最小且CAI最大,因此推断昆虫杆状病毒表达系统是FMDV VP1基因最适体外表达系统。本研究为FMDV亚单位疫苗研制等提供了技术基础。     

广东水禽源大肠埃希菌耐药性及氨基糖苷类耐药基因研究

为了调查广东地区水禽源大肠埃希菌对氨基糖苷类药物耐药现状和耐药基因的流行情况,探索大肠埃希菌的氨基糖苷类耐药基因型与耐药表型之间的关系,本研究采用琼脂梯度稀释法测定251株广东地区水禽源大肠埃希菌对氨基糖苷类药物的耐药性和采用PCR方法检测耐药基因。药敏试验结果显示,大肠埃希菌对链霉素耐药较严重,鸭源和鹅源的耐药率分别为81.58%和75.43%,对庆大霉素和卡那霉素较敏感,耐药率分别为25%和54.86%,对阿米卡星最为敏感,其中鸭源的菌株耐药率仅为1.32%。PCR方法检测显示,aadA1和aph(3′)-1检出率较高,为84.6%和91.9%,表明携带aadA1和aph(3′)-1耐药基因的水禽源大肠埃希菌在广东地区呈流行趋势。耐药基因型与耐药表型相关性分析结果显示,耐药基因rmtB的携带与4种药物(庆大霉素、阿米卡星、卡那霉素和壮观霉素)耐药株的产生具有显著相关性,表明耐药基因rmtB对大肠埃希菌耐药株的产生起重要的作用。本试验结果可为指导广东地区水禽大肠埃希菌病的临床用药提供理论基础和研究大肠埃希菌的耐药基因提供相关的数据。